View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Gemcitabine 1000 / Capecitabine 830, Pancreatic Cancer Adjuvant
Protocol-ID: 766 V1.2 (Mini), GEMC1000/CAPE830, Pancreatic Ca, adj.Indication(s)
- Pancreatic Cancer; ICD-10 C25.-
Links
- ASCO 2016: Adding Capecitabine Chemotherapy to Gemcitabine Extends Survival After Pancreatic Cancer Surgery [URL]
- ESPAC-4: A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma(Abstract: LBA4006). [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 19.12.2023